Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.650
+0.060 (3.77%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Evaxion Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
1052643102-
Upgrade
Market Cap Growth
-80.92%-80.92%-39.34%-58.12%--
Upgrade
Enterprise Value
1515232794-
Upgrade
Last Close Price
1.654.2334.2888.75221.00-
Upgrade
PS Ratio
0.531.48355.98---
Upgrade
PB Ratio
-6.31-3.00-5.495.163.15-
Upgrade
P/TBV Ratio
---5.163.16-
Upgrade
EV/Sales Ratio
4.364.63320.29---
Upgrade
Debt / Equity Ratio
-6.11-6.11-2.301.240.110.00
Upgrade
Asset Turnover
0.260.260.00---
Upgrade
Quick Ratio
1.791.790.943.857.881.63
Upgrade
Current Ratio
2.012.011.184.518.032.22
Upgrade
Return on Equity (ROE)
---1238.11%-113.74%-124.29%-183.15%
Upgrade
Return on Assets (ROA)
-72.57%-72.57%-79.47%-50.78%-61.95%-89.85%
Upgrade
Return on Capital (ROIC)
-126.22%-126.22%-112.34%-57.75%-74.78%-125.85%
Upgrade
Earnings Yield
-101.39%-213.08%-85.14%-54.08%-23.98%-
Upgrade
FCF Yield
-124.16%-260.93%-68.41%-60.85%-22.71%-
Upgrade
Buyback Yield / Dilution
-96.24%-96.24%-15.64%-21.27%-26.29%-11.10%
Upgrade
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q